在晚期心力衰竭患者机械循环支持后的电生理学变化
J D Harding1, V Piacentino, J P Gaughan
1Cardiovascular Research Group, Temple University School of Medicine, Philadelphia, PA, USA.
Circulation
|September 12, 2001
概括
在心力衰竭患者中,左心室辅助装置 (LVAD) 植入急性改变了心室导电和再极化. 持续的LVAD支持逆转了电生理学重塑,改善了心脏功能.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 使用左心室辅助装置 (LVAD) 的机械循环支持改变了心肌结构和功能.
- 了解LVAD后的电生理学变化对于管理心力衰竭至关重要.
研究的目的:
- 为了研究LVAD植入失败的人类心脏后心室导电和再极化变化的变化.
- 评估血液动力学卸载对心脏电生理学的影响.
主要方法:
- 在LVAD植入前和之后,分析了23名心力衰竭患者的12导电心电图 (ECG).
- 将心电图变化与接受冠状动脉旁路移植 (CABG) 的22名患者进行比较.
- 相关的心电图发现与心脏移植的肌细胞研究.
主要成果:
- 放置LVAD急剧减少了QRS持续时间,增加了QT持续时间和QTc间隔.
- 在CABG患者中没有观察到这些直接变化.
- 持续的LVAD支持显著降低了QTc间隔,由肌细胞中的动作潜能持续时间降低证实.
结论:
- 在LVAD后的急性心电图变化突出显示了QRS和QT持续时间的负载依赖性.
- 延迟的QTc和行动潜能持续时间的减少表明电生理学重塑的逆转.
- 缩短的作用电位持续时间可能有助于改善LVAD支持后的细胞收缩性.
相关概念视频
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


